# Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes

> **NCT07503548** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Diabete Mellitus

## Interventions

- **DRUG:** tributyrin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07503548
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-26
- **Primary completion:** 2026-08-26
- **Final completion:** 2026-08-26
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07503548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07503548, "Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07503548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*